Rhythm Pharmaceuticals, Inc. (RYTM) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Rhythm Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -35.39x | -13.10x | -14.36x | -8.38x | -7.11x | -10.04x |
| P/B Ratio | 50.02x | 20.75x | 15.62x | 5.74x | 1.74x | 7.88x |
| P/S Ratio | 36.66x | 26.24x | 34.24x | 64.21x | 156.95x | 0.00x |
| Profitability | ||||||
| Gross Margin | 89.7% | 89.7% | 88.0% | 91.0% | 81.0% | 0.0% |
| Operating Margin | -101.2% | -204.0% | -238.1% | -757.9% | -5391.9% | 0.0% |
| Net Margin | -103.6% | -200.3% | -238.5% | -766.2% | -2207.1% | 0.0% |
| EBITDA Margin | -91.8% | -183.0% | -217.6% | -737.1% | -2170.4% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 4.41x | 3.24x | 5.58x | 8.90x | 7.10x | 10.10x |
| Quick Ratio | 4.16x | 3.08x | 5.43x | 8.83x | 7.10x | 10.10x |
| Leverage | ||||||
| Debt/Equity | 1.77x | 0.02x | 0.01x | 0.01x | 0.01x | 0.02x |
YoY = year-over-year change. Source: FMP..